Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion type Assertion NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_head.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion description "[In addition, we summarize relevant patents on RhoA/Rho kinase and p21-activated kinase as targets of anti-cancer therapy and discuss the clinical potential of different approaches to modulate RhoA/Rho kinase and p21-activated kinase signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion evidence source_evidence_literature NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion SIO_000772 19519534 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion wasDerivedFrom befree-20140225 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion wasGeneratedBy ECO_0000203 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.